News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nobel Biocare Proposes Synthes, Inc. (SYST)' Orsinger as Chairman


7/6/2011 9:35:11 AM

Nobel Biocare AG proposed Synthes Inc. (SYST) Chief Executive Officer Michel Orsinger as its new chairman, replacing Heino von Prondzynski. Orsinger’s appointment takes effect early next year, Nobel said in a statement on its website today. He will start attending board meetings immediately as a guest, the Glattbrugg, Switzerland-based company said. Nobel in April reported a 67-percent drop in first-quarter net income to 12.9 million euros ($19 million) and submitted a non-binding bid for AstraZeneca’s Astra Tech dental-implant business. Vice Chairman Rolf Watter will head the board on an ad-interim basis, the company said.

Read at Bloomberg
Read at SF Gate
Read at Reuters

comments powered by Disqus
Bloomberg
SF Gate
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES